CGT

11개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved11 programs
CGTLimited DatastaleGeneplus-Beijing Co. Ltd.Phase 2

DC-CIK (DC-CIK)

Renal Cell Carcinoma · Renal Neoplasma

#RenalNeoplasma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Recruiting
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

CD70 CAR T-cells (CD70 CAR T-cells)

Metastatic Tumor; Renal Cell Carcinoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 31Status Active
CGTAAVLimited DatastaleAdrenas Therapeutics IncPhase 2

AAV BBP-631 (AAV BBP-631)

Congenital Adrenal Hyperplasia · Congenital Adrenal Hyperplasia

#CongenitalAdrenalHyperplasia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleUTC Therapeutics Inc.Phase 1

Anti-CD70 CAR-T cells (Anti-CD70 CAR-T cells)

Renal Cell Carcinoma · CD70-positive Advanced Urologic Neoplasm

#CD70-positiveAdvancedUrologicNeo#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Discontinued
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

(PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte (PG13-A(F/K-F-SGSG-T2a-B (opt, (PG13-A(F/K-F-SGSG-T2a-B (opt) (2G-1 TCR) retroviral vector-transduced lymphocyte)

Renal Cancer; Kidney Cancer · Renal Cancer

#RenalCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

2G-1 TCR Retroviral Vector-Transduced lyn (2G-1 TCR Retroviral Vector-Transduced lyn)

Renal Cancer; Kidney Cancer · Renal Cancer

#RenalCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleAdicet TherapeuticsPhase 2

ADI-270 (ADI-270)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

Anti-MAGE-A3-DP4 T Cell Receptor (TCR, Anti-MAGE-A3-DP4 T Cell Receptor, Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL))

Cervical Cancer; Renal Cancer · Cervical Cancer

#CervicalCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

Anti-hCD70 CAR transduced PBL (Anti-hCD70 CAR transduced PBL)

Pancreatic Cancer; Renal Cell Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleAMERICAN ORGAN TRANSPLANT AND C…Phase 2

Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney (Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney)

End-Stage Renal Disease; End Stage Renal Disease on Dialysis · End-Stage Renal Disease

#End-StageRenalDisease#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

PG13-MAGE-A3 TCR9W11 (anti-MAGE-A3/12 TCR, PG13-MAGE-A3 TCR9W11, PG13-MAGE-A3 TCR9W11 (anti-MAGE-A3/12 TCR) Transduced Autologous Peripheral Blood Lymphocytes)

Metastatic Cancer; Metastatic Renal Cancer · Metastatic Cancer

#MetastaticCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued